Éruption bulleuse locale après extravasation de produit de contraste iodé
M. Carreiro, P. Arlet(Centre de Référence Déficits Immunitaires Héréditaires), Patricia Chemla, L. Sailler(Université Fédérale de Toulouse Midi-Pyrénées), S. Ollier(Institut universitaire du cancer de Toulouse Oncopole), Nathalie Margarit-Coll, Serge Dahan(Unknown)
La Presse Médicale
February 29, 2008
Cited by 0
Related Papers
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
|Journal of Allergy and Clinical Immunology|2017|316
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207
Nonablative Remodeling: Clinical, Histologic, Ultrasound Imaging, and Profilometric Evaluation of a 1540 nm Er:Glass Laser
|Dermatologic Surgery|2001|155
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus
|Arthritis & Rheumatology|2015|140